Dynavax Technologies Corporation (DVAX)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
16.46+0.42 (+2.62%)
As of 11:03 AM EDT. Market open.
People also watch:
NVAXACADCYTKKERXBCRX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open16.07
Prev Close16.04
Bid16.36 x 100
Ask16.37 x 200
Day's Range15.95 - 16.46
52wk Range12.84 - 32.49
1y Target EstN/A
Market Cap633.66M
P/E Ratio (ttm)-5.46
Beta1.04
Volume106,729
Avg Vol (3m)565,804
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube52 minutes ago

    ETF’s with exposure to Dynavax Technologies Corp. : August 25, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Dynavax Technologies Corp. Here are 5 ETF’s with the largest exposure to DVAX-US. Comparing the performance and risk of Dynavax Technologies Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube13 days ago

    ETF’s with exposure to Dynavax Technologies Corp. : August 12, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Dynavax Technologies Corp. Here are 5 ETF’s with the largest exposure to DVAX-US. Comparing the performance and risk of Dynavax Technologies Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
    Capital Cube15 days ago

    Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016

    Categories: Yahoo Finance Click here to see latest analysis Dynavax Technologies Corp. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Dynavax Technologies Corp. – Agenus Inc., Biogen Inc., Idera Pharmaceuticals, Inc., Merck & Co., Inc., Gilead Sciences, Inc., Momenta Pharmaceuticals, Inc., Astrazeneca PLC Sponsored ADR, Vical ... Read more (Read more...)